Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review

 Published On: Jul, 2017 |    No of Pages: 46 |  Published By: GlobalData | Format: PDF
Request Free Sample

Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.
- Corporate strategy - Analyst's summarization of the company's business strategy.
- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Novozymes A/S (Novozymes) is a biotech company that produces and sells industrial enzymes and microorganisms. The company develops, produces and distributes enzymes for detergent, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning and wastewater treatment. Novozymes provides various biopharmaceutical ingredients for the pharmaceutical industry. The company caters products to various industries such as household care, agriculture, biopharmaceuticals, bioenergy, food and beverages, pulp and paper, leather, wastewater and textiles. It has operational presence in various countries such as Denmark, China, India and the US among other countries. Novozymes is headquartered in Bagsvaerd, Denmark.

Novozymes AS Key Recent Developments

Jun 27,2017: DONG Energy: One of the largest power stations in Denmark can phase out coal
Mar 23,2017: Residues from Novo Nordisk and Novozymes to be converted into biogas
Dec 05,2016: Monsanto Company and Novozymes launch corn inoculant Acceleron B-300 SAT
Jun 30,2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK
Jun 29,2016: Novozymes and DONG Energy enter into agreement on biological waste sorting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Novozymes A/S - Key Facts 5
Novozymes A/S - Key Employees 6
Novozymes A/S - Key Employee Biographies 7
Novozymes A/S - Major Products and Services 8
Novozymes A/S - History 9
Novozymes A/S - Company Statement 12
Novozymes A/S - Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 - Company Analysis 17
Novozymes A/S - Business Description 17
Novozymes A/S - Corporate Strategy 18
Novozymes A/S - SWOT Analysis 19
SWOT Analysis - Overview 19
Novozymes A/S - Strengths 19
Novozymes A/S - Weaknesses 20
Novozymes A/S - Opportunities 21
Novozymes A/S - Threats 22
Novozymes A/S - Key Competitors 23
Section 3 - Company Financial Ratios 24
Financial Ratios - Capital Market Ratios 24
Financial Ratios - Annual Ratios 25
Performance Chart 28
Financial Performance 28
Financial Ratios - Interim Ratios 29
Financial Ratios - Ratio Charts 30
Novozymes A/S, Recent Deals Summary 31
Section 4 - Company's Recent Developments 32
Jun 27, 2017: DONG Energy: One of the largest power stations in Denmark can phase out coal 32
Mar 23, 2017: Residues from Novo Nordisk and Novozymes to be converted into biogas 33
Dec 05, 2016: Monsanto Company and Novozymes launch corn inoculant Acceleron B-300 SAT 35
Jun 30, 2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK 36
Jun 30, 2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK 37
Jun 30, 2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK 38
Jun 29, 2016: Novozymes and DONG Energy enter into agreement on biological waste sorting 39
Jan 19, 2016: Group Financial Statement for 2015: Novozymes 40
Jan 19, 2016: Novozymes separates its biopharma activities to form independent company 41
Section 5 - Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Novozymes A/S, Key Facts 5
Novozymes A/S, Key Employees 6
Novozymes A/S, Key Employee Biographies 7
Novozymes A/S, Major Products and Services 8
Novozymes A/S, History 9
Novozymes A/S, Subsidiaries 14
Novozymes A/S, Key Competitors 23
Novozymes A/S, Ratios based on current share price 24
Novozymes A/S, Annual Ratios 25
Novozymes A/S, Annual Ratios (Cont...1) 26
Novozymes A/S, Annual Ratios (Cont...2) 27
Novozymes A/S, Interim Ratios 29
Novozymes A/S, Recent Deals Summary 31
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45

List of Figures
Novozymes A/S, Performance Chart (2012 - 2016) 28
Novozymes A/S, Ratio Charts 30


If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.